Business Standard

CMC Vellore calls for volunteers for Covaxin vaccine booster dose trials

The findings for recipients of Covishield will be released along with those with Covaxin trial data once the study for both vaccines is over

Covaxin
Premium

Pune-based Serum Institute of India (SII) has already sought approval for a Covishield booster dose

Ruchika Chitravanshi New Delhi
In India’s first clinical study being conducted for booster doses, the Christian Medical College (CMC) in Vellore is looking to recruit volunteers who have taken both the doses of Covaxin, three to six months ago. 

In August, the Drug Controller General of India (DCGI) had given its approval to CMC Vellore to conduct the clinical trials for booster doses. The institute was easily able to recruit 200 participants who had taken Covishield but has not been able to find an equal number of people vaccinated with Covaxin for the third jab. 

“It is understandable since almost 88 per cent of the vaccines

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in